Center-Authored Papers

Filters: Author is Baik, Christina S  [Clear All Filters]
Journal Article
Yan J, Liu Q, Moseley JN, Baik CS, Chow LQM, Goulart BH, Zlotnick D, Papanicolau-Sengos A, Gallaher I, Knopp JM et al..  2016.  Adjuvant Radiotherapy for Stages II and III Resected Thymoma: A Single-Institutional Experience.. American journal of clinical oncology. 39(3):223-227. Abstract
Planchard D, Besse B, Groen HJM, Souquet P-J, Quoix E, Baik CS, Barlesi F, Kim TM, Mazieres J, Novello S et al..  2016.  Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.. The Lancet. Oncology. 17(7):984-93. Abstract
Baik CS, Wu D, Smith C, Martins RG, Pritchard CC.  2015.  Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 10(10):e97-9.
Baik CS, Pritchard CC, Eaton KD, Chow LQ.  2013.  EGFR mutations in squamous cell lung cancer in never-smokers.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 8(1):e6-7.
Hanash SM, Baik CS, Kallioniemi O.  2011.  Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer.. Nature reviews. Clinical oncology. 8(3):142-50. Abstract
Baik CS, Rubin EH, Forde PM, Mehnert JM, Collyar D, Butler MO, Dixon EL, Chow LQM.  2017.  Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(17):4992-5002. Abstract
Brasky TM, Liu J, White E, Peters U, Potter JD, Walter RB, Baik CS, Lane DS, Manson JE, Vitolins MZ et al..  2014.  Non-steroidal Anti-inflammatory Drugs and Cancer Risk in Women: Results from the Women's Health Initiative.. International journal of cancer. Journal international du cancer. Abstract
Brasky TM, Baik CS, Slatore CG, Potter JD, White E.  2012.  Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study.. Lung cancer (Amsterdam, Netherlands). 77(2):260-4. Abstract
Baik CS, Brasky TM, Pettinger M, Luo J, Gong Z, Wactawski-Wende J, Prentice RL.  2015.  Nonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(5):790-7. Abstract
Chow LQM, Morishima C, Eaton KD, Baik CS, Goulart BH, Anderson LN, Manjarrez KL, Dietsch GN, Bryan JK, Hershberg RM et al..  2016.  Phase 1b Trial of the Toll-Like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Brasky TM, Baik CS, Slatore CG, Alvarado M, White E.  2012.  Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 7(10):1503-12. Abstract
Ferreira BP, Redman M, Baker KK, Martins R, Eaton KD, Chow LQM, Baik CS, Goulart B, Lee SM, Santana-Davila R et al..  2016.  Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.. The Laryngoscope. Abstract
Chamberlain MC, Baik CS, Gadi VK, Bhatia S, Chow LQM.  2017.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.. Neuro-oncology. 19(1):i1-i24. Abstract
Baik CS, Chamberlain MC, Chow LQ.  2015.  Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
Baik CS, Myall NJ, Wakelee HA.  2017.  Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.. The oncologist. Abstract